Cellosaurus cell line NS0-hCD20 (CVCL

Cross-references
Cell line name	NS0-hCD20
Synonyms	NS/0-hCD20; NSO/CD20
Accession	CVCL_C6XI
Resource Identification Initiative	To cite this cell line use: NS0-hCD20 (RRID:CVCL_C6XI)
Comments	Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7315; MS4A1.
Disease	Mouse plasma cell myeloma (NCIt: C125417)
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090) Breed/subspecies: BALB/c.
Hierarchy	Parent: CVCL_3940 (NS0)
Sex of cell	Female
Category	Cancer cell line
Publications	Patent=US8329181 Martin J.H., Wang L.-H., Stevens S., Allison E.M. Methods for treating B-cell lymphoma by administering an anti-CD20 antibody. Patent number US8329181, 11-Dec-2012 PubMed=26659273; DOI=10.1038/srep17943; PMCID=PMC4675964 Smith E.J., Olson K., Haber L.J., Varghese B., Duramad P., Tustian A.D., Oyejide A., Kirshner J.R., Canova L., Menon J., Principio J., MacDonald D., Kantrowitz J., Papadopoulos N.J., Stahl N., Yancopoulos G.D., Thurston G., Davis S. A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Sci. Rep. 5:17943-17943(2015)
Encyclopedic resources	Wikidata; Q117704733
Entry history
Entry creation	21-Mar-2023
Last entry update	19-Dec-2024
Version number	4